Clinical Trials on Hyperglycaemia During Perioperative Period in Canada
Total 0 results
Nothing found
Sponsors and Collaborators
- Orthopädisch-Unfallchirurgische Praxis Dr Lembeck & Dr Pampel
- Pearl Network
- EndoTheia
- Retina Foundation of Canada
- Department of Orthopedics, Norrköping
- Critical Care Pharmacotherapy Trials Network
- kıvan çevik kaya
- South Texas Health System McAllen
- Jinxiang County People's Hospital
- Hospital Santos Reyes de Aranda de Duero, Burgos
- Phoenix VA Health Care System
- Canadian Glycomics Network (GlycoNet)
- Alcohol Education and rehabilitation Fund
- EXCELYA Bordeaux
- Rivus Pharmaceuticals, Inc.
- Dr. Khaled Ahmed Yassen
- Merve Şeker
- Bettina Eiger
- Diabetes Research Institute, Munich, Germany.
- Clinic of the International Institute of Postgraduate Education Ministry of Healthcare of the Republic of Kazakhstan
- View Full List
Medical Conditions
- Encephalitis, Arbovirus
- Myocardial Haemorrhage
- Acute Rotator Cuff Tear Related to Trauma
- Presence / Absence of EBV
- Dystonic Disorders
- Malignant Pelvic Neoplasm
- Racial Bias
- Cystic Renal Disease
- Deep Neck Space Infections
- Myocardial Infarction (MI) or Acute Myocardial Infarction (AMI)
- Morton's Neuroma
- Poststroke Fatigue
- Ruptured Achilles Tendon
- Secondary Pulmonary Arterial Hypertension
- Tumor Cell, Circulating
- 1- Primary (Sarcomeric) Hypertrophic Cardiomyopathy
- Newborn Infants
- Organic Anion Transporting Polypeptide1B1 (OATP1B1)
- Fluorescein Angiography
- Acute Upper Gastrointestinal Non Variceal Hemorrhage
- View Full List
Drug Interventions
- Sodium Nitroprusside
- Percutaneous sirolimus
- Anastrozole
- Trastuzumab in combination with SubQ GM-CSF
- Follitropin beta liquid formulation
- Visanne (Dienogest, BAY86-5258)
- Tenofovir
- Vinorelbine tartrate
- PCO371
- Sipuleucel-T
- 5.0g SRT501
- Modified Bolus 5-FU/LV with Irinotecan
- Ketamine 0.3 mg/kg at anesthesia induction
- Amisulpride Oral Tablet
- Nicoderm C-Q Transdermal Product
- Cetuximab
- 6-Mercaptopurine
- Granulocyte colony-stimulating factor
- 30 mg CVL-231 as slow-release MR formulation
- Tranexamic acid
- View Full List
CROs by country
- Contract Research Organizations in Gabon
- Contract Research Organizations in Greece
- Contract Research Organizations in Hungary
- Contract Research Organizations in Italy
- Contract Research Organizations in Kenya
- Contract Research Organizations in Nigeria
- Contract Research Organizations in Poland
- Contract Research Organizations in Saint Lucia
- Contract Research Organizations in Trinidad & Tobago
- Contract Research Organizations in Tunisia
- Contract Research Organizations in Türkiye
- Contract Research Organizations in United States
- Contract Research Organizations in Venezuela
- CRO list by country